Introduction
The p53 tumor suppressor maintains the normal growth control and genomic stability by either imposing a G1 cell cycle arrest or inducing apoptosis in response to DNA damage and other forms of cell stress (Prives and Hall, 1999; Rich et al., 2000; Vogelstein et al., 2000; Vousden and Lu, 2002) . In the development of most human cancers, the p53 pathway is often disrupted by either oncogenic mutations in p53 itself, expression of oncoproteins or defective regulations upstream to p53 (Vogelstein et al., 2000) . Growing evidences have shown that the proapoptotic function of p53 is essential for its tumor suppressor activity (Clarke et al., 1993; Lowe et al., 1993; Schmitt et al., 2002) and because of this, search for the major apoptotic mediator of p53 has attracted increasing attentions recently.
The mechanism of how p53 triggers cell death has been more focused on Puma/Bbc3 recently. Puma (p53 upregulated modulator of apoptosis) was initially identified as a p53-inducible gene by differential expression analyses (Nakano and Vousden, 2001; Yu et al., 2001) and as a Bcl-2 binding protein by yeast two-hybrid assay (Han et al., 2001) . It has been shown that Puma was a potent proapoptotic BH3 (Bcl-2 homology)-only protein, which can induce apoptosis in various cancer cells within a few hours and this apoptotic activity requires its intact BH3 domain (Han et al., 2001; Nakano and Vousden, 2001; Yu et al., 2001) . Evidences obtained from Puma knockout mice further validate the role of Puma identified in cultured cell lines for inducing apoptosis. All these in vitro studies along with findings derived from a somatic knockout tumor cell line (Yu et al., 2003) suggest that Puma plays an essential role in apoptotic induction. Expression of Puma is crucial for hematopoietic cell death, which is p53-dependent, triggered by ionizing radiation (IR) or deregulated c-Myc expression (Jeffers et al., 2003) . It is not surprising to see that Puma deficiency was able to protect cells against p53-independent apoptotic stimuli such as cytokine deprivation, glucocorticoids, the kinase inhibitor staurosporine or phorbol esters (Villunger et al., 2003) .
Myeloid cell leukemia-1 (Mcl-1) is also a Bcl-2 family protein and was originally cloned as an early induction gene from human myeloid leukemia cell line ML-1 (Kozopas et al., 1993) . Subsequent functional studies have confirmed that Mcl-1 acts as an antiapoptotic protein and is capable of blocking apoptosis induced by various apoptotic stimuli, including c-Myc overexpression (Reynolds et al., 1994) , staurosporine (Reynolds et al., 1996) , etopside, calcium ionophore A23187 and UV irradiation (Zhou et al., 1997) . More importantly, antisense or RNAi strategy showed that the antiapoptotic function of Mcl-1 is essential for maintenance of cell viability Derenne et al., 2002; Nijhawan et al., 2003) . Although Mcl-1 possesses BH1, BH2 and BH3 domains similar to those in other related Bcl-2 family members, one feature, however, sets it apart from other Bcl-2 homolog. Mcl-1 contains a PEST (proline, glutamic acid, serine, and threonine) sequence (Rogers et al., 1986) in its Nterminal region previously attributed to the short halflife of Mcl-1 (Kozopas et al., 1993; Yang et al., 1995) . In addition to its intrinsic instability character, level of Mcl-1 can be readily up-or downregulated by certain stimuli (Kozopas et al., 1993; Yang et al., 1996; Zhan et al., 1997; Nijhawan et al., 2003) . Recently, Opferman et al. (2003) reported that Mcl-1 was also mandatory for the development and maintenance of B and T Lymphocytes.
Huang and co-workers recently found an interaction between Puma and Mcl-1 when they studied the differential targeting of Bcl-2 prosurvival proteins by BH3-only ligands (Chen et al., 2005) . Nevertheless, the mechanism underlying this interaction has not been investigated in great detail. In this study, we reported that Mcl-1 is a specific binding partner for Puma. Their binding sites have been mapped to BH1 domain for Mcl-1 and BH3 domain for Puma. We also demonstrated that Mcl-1 and Puma were colocalized at mitochondria. Furthermore, we found ectopic expression of Mcl-1 was able to inhibit Pumainduced apoptosis; however, this protection will become ineffective when Puma was at a relatively high level. More importantly, we found that when coexpressed with Puma, the stability of Mcl-1 was increased through its binding to Puma. This Pumaenhanced stabilization of Mcl-1 was also validated in vivo under nonoverexpression conditions. Finally, we concluded that binding of Puma to BH1 domain of Mcl-1 is not sufficient to prevent rapid degradation of Mcl-1.
Results

Identification of Mcl-1 as a Puma-interacting partner
We performed a yeast two-hybrid screen using fulllength Puma as bait to isolate possible Puma-interacting proteins from a HeLa cDNA library. Among 1 Â 10 6 independent clones screened on SD/ÀAde/ÀHis/ÀLeu/ ÀTrp plates, we identified 15 candidate clones. Sequence analyses revealed that five of these clones were coding for Mcl-1 with 219 amino acids truncated at its N terminus. We named these five clones 'M01'. To verify the interactions between Puma and M01 or full-length Mcl-1, the yeast two-hybrid assay was employed and the results were shown in the Figure 1a . Both M01 and Mcl-1 were found to specifically interact with full-length Puma.
To test if Mcl-1 is able to interact with Puma in mammalian cells, 293T cells (the reason we used 293T cell line is because we observed that this cell line is resistant to Puma induction) were cotransfected with pCDNA3-Flag/Puma and either pEGFP-C1/ Mcl-1 or pEGFP-C1. Cell lysates were immunoprecipitated with anti-GFP antibody, and subjected to Western blot analysis to detect bound Puma using anti-Flag antibody. As shown in Figure 1b To examine whether this interaction between Puma and Mcl-1 could be detected under nonoverexpression conditions, two isogenic colorectal cancer cell lines HCT116 Puma wild type (Puma þ / þ ) and null (PumaÀ/À) were used. Lysates from 2 Â 10 7 PumaÀ/À and Puma þ / þ HCT116 cells were precipitated individually by anti-Mcl-1 antibody and followed by immunoblotting with anti-Puma antibody. Puma was detected in the immunoprecipitates from Puma þ / þ HCT116 cells, but not from PumaÀ/À HCT116 cells (Figure 1c, top panel) . This result suggests that Mcl-1 physically interacts with Puma even in a nonapoptotic condition. By binding to Mcl-1, Puma may play some roles in maintaining the basal level of Mcl-1 in normal growing cells. However, the exact biological significance for Puma/Mcl-1 binding in the absence of apoptotic stimulus awaits further investigation.
Mapping the binding domains involved in the interactions between Mcl-1 and Puma
To identify the region of Mcl-1 that mediates the interaction of Puma, truncated deletion mutants of Mcl-1 (M1-M5) were generated and their ability to bind to Puma was tested by co-immunoprecipitation assay. Besides BH1, BH2 and BH3 domains, Mcl-1 contains two additional PEST motifs and a transmembrane domain (Kozopas et al., 1993) . M1-M4 represents Mcl-1 C-terminal truncations by deleting the domains of TM, BH2, BH1 and BH3 progressively from its C-terminus. M5 represents an Mcl-1 deletion mutant lacking only BH1 domain ( Figure 2a ). As shown in Figure 2b , while full-length Mcl-1, and mutants M1 and M2 exhibited strong interaction with Puma (right panel, lanes 1-3), M3, M4 and M5 has lost the ability to interact with it (right panel, lanes 4-6), indicating that the BH1 domain of Mcl-1 is essential for its interaction with Puma.
Puma is a BH3-only Bcl-2 family protein (Han et al., 2001; Nakano and Vousden, 2001; Yu et al., 2001) . Three Puma deletion mutants (P1-P3) were constructed to determine the region essential for the interaction with Mcl-1 (Figure 2c ). Co-immunoprecipitation assay was similarly performed and the results were shown in Figure 2d . We have demonstrated by co-IP experiment that the BH3 domain of Puma is required for its interaction with Mcl-1. To further verify this conclusion, we performed fluorescent imaging studies. HeLa cells were transfected with pEGFP-C1/Mcl-1 or cotransfected with pEGFP-C1/Mcl-1 plus pCDA3-Flag/Puma-DBH3, as shown in Figure 3b , unlike wild-type Puma, Puma-DBH3 is incompetent to direct diffused Mcl-1 to localize at mitochondria, reflecting that the interactions between Mcl-1 and Puma is directly associated with their mitochondrial colocalization. Similar to wt-Puma, mitochondrial localization of Puma-DBH3 was also shown, when compared with MitoTracker red dye ( Figure 3c ). Taken together, we conclude that the interactions between Mcl-1 and Puma appear to take place at the mitochondria.
Ectopic expression of Mcl-1 antagonizes Puma-induced apoptosis
Mcl-1 is an antiapoptotic protein that has been reported to inhibit apoptosis induced by various stimuli (Reynolds et al., 1994 (Reynolds et al., , 1996 Zhou et al., 1997) . To examine whether Mcl-1 was able to protect the cells from apoptosis triggered by Puma, HeLa cells in 24-well plates were cotransfected with fixed amount of pCDNA3-Flag/Mcl-1 (0.3 mg) plus increasing amounts of pEGFP-C1/Puma (0.1, 0.2 and 0.3 mg) separately. In accordance with previous studies, we found Puma's capability of inducing apoptosis was so strong that 0.1 mg of transfected Puma DNA could cause almost 100% cell death within 24 h ( Figure 4A ). We also noticed that Mcl-1 can effectively inhibit Puma-induced apoptosis only when transfected Puma was at lower level (0.1 mg). By increasing transfected Puma from 0.1 to 0.2 mg, 70% protection by Mcl-1 was abruptly dropped to nearly 0% and cells transfected with more than 0.2 mg of Puma were shown to cause 100% apoptosis ( Figure 4A ), indicating the potent apoptosisinducing capability of Puma and the limited inhibitory effect of Mcl-1. These findings may partly explain why Mcl-1 can only promote short-term viability in a variety of cell types (Reynolds et al., 1994 (Reynolds et al., , 1996 Zhou et al., 1997 Zhou et al., , 1998 Mcl-1 blocks Puma-mediated cytochrome c release and subsequent activation of caspase-9
Previous studies have shown that Puma mediates the release of cytochrome c from mitochondria to cytosol and subsequently the activation of caspase-9 (Nakano and Vousden, 2001 ). Here, we investigated if Mcl-1 could block cytochrome c release during Puma-induced apoptosis. HeLa cells in six wells were either cotransfected with pEGFP-C1/Puma (1 mg) and pCDNA3-Flag/Mcl-1 (3 mg) or transfected with pEGFP-C1/Puma (1 mg) alone. As shown in Figure 4B , Puma promotes cytochrome c release from mitochondria in a timedependent manner and Mcl-1 can effectively block this cytochrome c release. These results further supported that Puma mediated apoptosis is through mitochondria, and moreover, the antiapoptotic function of Mcl-1 acts upstream or parallel to the mitochondria. Cytochrome c is a cofactor for Apaf-1-dependent caspase-9 activation (Li et al., 1997) ; we also tested whether the expression of Mcl-1 blocks caspase-9 activation. As shown in Figure 4C , Mcl-1 was indeed found to greatly reduce caspase-9 activation. The reduced cleavage of PARP, a direct downstream substrate of caspases-9 was also detected in the presence of Mcl-1.
The stability of Mcl-1 is increased by its binding to Puma
The level of the Mcl-1 was found to be increased when it coexpressed with Puma ( Figure 1b , bottom right panel), which reminds us to inquire whether Mcl-1 is stabilized by binding to Puma. To address this issue, HeLa cells were cotransfected with pCDNA3-Flag/Mcl-1 (3 mg) and either pEGFP-C1 (1 mg), pEGFP-C1/Puma-DBH3 (1 mg) or pEGFP-C1/Puma (1 mg) respectively. As shown in Figure 5A Figure 5A(b) ), despite that Bcl-2 was reported to bind to Puma as well (Han et al., 2001; Nakano and Vousden, 2001; Yu et al., 2001) , which may be explained by the fact that Bcl-2 does not have a short half-life like Mcl-1.
Based on our finding, Puma was unable to induce apoptosis in 293T cells, we therefore cotransfected 293T cells in six-well plate with fixed amount of pCDNA3-Flag/Mcl-1 (4 mg) and increasing amounts of pEGFP-C1/Puma (0-4 mg). As shown in Figure 5B , levels of Mcl-1 protein were concurrently increased with increasing expression of Puma, further indicating the stabilization of Mcl-1 is specific to Puma.
To understand whether the increased stability of Mcl-1 is independent of its protein synthesis, a pulsechase experiment was performed. 293T cells were cotransfected with pCDNA3-Flag/Mcl-1 (4 mg) and either pEGFP-C1 (4 mg) or pEGFP-C1/Puma (4 mg). At 24 h after transfection, cells were pulse-labeled with [ 35 S]cysteine/methioninefor 5 h; chased with DMEM containing 10% FBS; harvested at 0, 1, 2 and 3 h; and subjected to immunoprecipitation using anti-Flag antibody. Precipitated Flag-Mcl-1 was subjected to SDS-PAGE and autoradiography by quantification of radioactivity present in the bands. As shown in Figure 6a , level of 35 S-labeled Mcl-1 in the cells cotransfected with pCDNA3-Flag/Mcl-1 and pEGFP-C1 decreases dramatically, and after 2 h chase time, labeled Mcl-1 was hardly detectable. In contrast, in cells cotransfected with pCDNA3-Flag/Mcl-1 and pEGFP-C1/Puma, labeled Mcl-1 was shown to be much more stable, even after 3 h chasing, approximately 60% of labeled Mcl-1 was able to be detected, suggesting that Puma is able to stabilize Mcl-1 in the absence of de novo Mcl-1 synthesis.
Next, to examine whether this Puma-dependent stabilization of Mcl-1 exists in nonoverexpression conditions, two isogenic HCT116 cell lines that are wild type and null for Puma were employed. Both Puma þ / þ and PumaÀ/À HCT116 cells were individually pulselabeled with [ 35 S]cysteine/methionine for 5 h; chased with DMEM containing 10% FBS; harvested at 0, 1, 2 and 3 h; and subjected to immunoprecipitation using anti-Mcl-1 antibody. Precipitated Mcl-1 was subjected to SDS-PAGE and autoradiography by quantification of radioactivity present in the bands. Similar results were obtained as shown in Figure 6b , 35 S-labeled Mcl-1 was barely detectable in PumaÀ/À cells after 1 h chasing, whereas nearly 90% of Mcl-1 within Puma þ / þ cells was detectable even after 2 h chasing, this in vivo result further reinforces that Pumadependent Mcl-1 stabilization does occur in a nonoverexpression condition.
BH1 domain of Mcl-1 is necessary, but not sufficient for its degradation
The selective degradation of many short-lived proteins in eukaryotic cells is known to be mediated by specific degradation signals, which could be motifs or structural features of targeting proteins that are destined for rapid proteolysis (Laney and Hochstrasser, 1999) . Although Mcl-1 was reported to be degraded through the ubiquitin-proteasome pathway (Kozopas et al., 1993; Yang et al., 1995) , still it is not yet clear which regions are responsible for this rapid degradation. To address this issue, we prepared a series of constructs by linking GFP to the N-terminus of various Mcl-1 deletion mutants ( Figure 7A , upper panel). In total, 11 different constructs were transiently transfected into HeLa cells. After 24 h, cells were treated with or without MG132 (20 mM) for 12 h, and were then examined by Western blotting for evaluating protein stability ( Figure 7A , lower panel). On the one hand, PEST-only fragment GFP-Mcl-1 (PEST) shown in Figure 7A was subject to degradation in the absence of MG132, on the other 
Discussion
In this study, we showed that Mcl-1 physically interacts with Puma and this interaction appears to take place at mitochondria. We also delineated the interaction domains involved in the interactions between Puma and Mcl-1. Previous studies have shown that BH domains of Bcl-2 family members are necessary for their homodimerization or heterodimerization (Yin et al., 1994; Chittenden et al., 1995; Han et al., 1996) . Consistent with these findings, we conclude that Mcl-1 interacts with Puma via its BH1 domain. Furthermore, we have shown that the BH3 domain of Puma is essential for its interaction with Mcl-1. Our imaging studies showed that, unlike wt-Puma, Puma deletion mutant lacking a BH3 domain fails to direct diffused cytoplasmic Mcl-1 to localize at mitochondria, indicating that colocalization of Mcl-1 and Puma at mitochondria is indeed through their interactions involving Puma BH3.
Mcl-1, a member of Bcl-2 family, is capable of blocking apoptosis induced by various apoptotic stimuli (Reynolds et al., 1994 (Reynolds et al., , 1996 Zhou et al., 1997) ; however, the mechanism by which Mcl-1 inhibits apoptosis has not been conclusively determined. In our study, we demonstrated that ectopic expression of Mcl-1 suppressed apoptosis induced by Puma via its direct interaction with Puma, since Mcl-1 deletion mutant lacking BH1domain completely abrogated its inhibitory ability ( Figure 4A) . However, the ability of Mcl-1 to protect cell death was seen to be limited, since Mcl-1 is unable to inhibit apoptosis when the level of Puma is relatively high. This phenomenon is conceivable since Mcl-1 is a short-lived protein with a quick turnover rate; therefore, it is unlikely for cell to accumulate enough Mcl-1 to antagonize Puma. Puma is expected to gain the upper hand overwhelming Mcl-1 (because of the instability of Mcl-1) in an equilibrium between Puma and Mcl-1, Puma is able to induce apoptosis eventually. However, before the exact interaction mode between Puma and Mcl-1 to be clarified, this observation will remain conjectural. Limited inhibitory effect of Mcl-1 may partly explain why Mcl-1 can only produce moderate short-term viability enhancement in a variety of cell types (Reynolds et al., 1994 (Reynolds et al., , 1996 Zhou et al., 1997 Zhou et al., , 1998 .
Puma has been reported to induce rapid apoptosis and promote cytochrome c release from mitochondria (Han et al., 2001; Nakano and Vousden, 2001; Yu et al., 2001 Yu et al., , 2003 , which is in accordance with our results in this study. We found death signal of Puma can be transduced all the way down to PARP through cytochrome c and caspase-9. In contrast, Mcl-1 is able to counteract the apoptosis through inhibiting cytochrome c release from mitochondria.
Protein sequence analysis has suggested that the PEST motifs within Mcl-1 contribute to its high turnover rate (Kozopas et al., 1993; Yang et al., 1995; Yoon et al., 2002) . Consistent with this conclusion, we showed that PEST-only Mcl-1 deletion mutant was degraded in proteasome-dependent manner. However, we have demonstrated that Mcl-1 lacking PEST was degraded equally rapidly when compared with Mcl-1, which is in good agreement with the finding of Akgul et al. They reported that deletion of PEST sequences in Mcl-1 does not appear to improve its short half-life (Akgul et al., 2000) . Mcl-1 mutants lacking both PEST and BH1 domain, but retain C-terminal region from aa 303 to 350, are still subject to degradation and only those Mcl-1 mutants simultaneously lacking PEST, BH1 and C-terminal region, such as GFP-Mcl-1 (1-250)-DPEST or GFP/Mcl-1 (272-302), are not subject to protein degradation. Much surprise to us, we found that Puma is able to increase the Mcl-1 stability by direct binding to it. Stability of Mcl-1 was able to be increased by either proteosome inhibitor MG132 or by Puma; however, in the presence of both Puma and MG132, its stability reached to its apex. It is therefore not irrational to assume that forming a Puma/Mcl-1 complex renders Mcl-1 less susceptible to degradation by 26S proteosome. The exact mechanism underlying this enhanced stability of Mcl-1 by Puma awaits the further crystallographic studies. It has not been escaped from us that the binding of Mcl-1 to Puma only partially prevents its quick turnover; Mcl-1/Puma complex was still subject to some degree of proteasome-mediated degradation ( Figure 5A(c) ), indicating additional region besides BH1 of Mcl-1 or some factors other than Puma might also involve determining the stability of Mcl-1. Taken together, we propose that the interactions between Puma and Mcl-1 may partly conceal the degradation signal of Mcl-1, which is normally targeted by proteasome and this kind of interaction can greatly reduce but cannot completely abolish its proteasome-dependent protein degradation. Our result from the pulse-chase experiment showed that Puma-enhanced stability of Mcl-1 is independent of protein synthesis, and more importantly, enhanced Mcl-1 stabilization truly exists under nonoverexpression conditions, which indicates that endogenous Puma might be an important determinant for the prolonged half-life of Mcl-1. Wang and coworkers recently reported that in response to genotoxic stress, such as UV irradiation, protein synthesis of Mcl-1 will be blocked and the existing pool of Mcl-1 is subject to degradation by proteasome (Nijhawan et al., 2003) . Based on the data from both of our groups, we expect that at early stage of Puma-induced apoptosis, on the one hand, the stability of pre-existing Mcl-1 could be increased by the upregulated Puma, which might represent the damaging cell's instinctive response for survival in facing of the death stimulus, and on the other hand, Puma/Mcl-1 degradation processes still continue to take place. BH1 domain, one of several degradation signals of Mcl-1, directly interacts with BH3 domain of Puma in Puma/Mcl-1 complex; nevertheless, other Mcl-1 degradation signals such as PEST or C-terminus region are still uncovered by Puma, and therefore Mcl-1 in Puma/Mcl-1 is still being degraded by proteasome, albeit at a slower pace than Mcl-1 alone. In summary, data revealed from this study may offer an alternative therapeutic intervention of apoptosis or cell death by improving the stability of Mcl-1.
Materials and methods
Reagents and antibodies
The following antibodies were used in this study: polyclonal antibodies: anticaspase-9, antiactin and anti-PUMAa (N-19) (Santa Cruz Biotechnology, Santa Cruz, CA, USA); monoclonal antibodies: mAb-cytochrome c (R&D Systems, Inc., Minneapolis, MN, USA), mAb-bcl-2 (Oncogene, Manhasset, NY, USA), mAb-GFP (MBL, Japan), mAb-Flag (Sigma, St Louis, MO, USA) and mAb-Mcl-1 (BD Biosciences, Palo Alto, CA, USA). MG132 was purchased from Calbiochem. Hoechst 33342 and cycloheximide were obtained from Sigma. MitoTracker Red CMXRos was purchased from Molecular Probes (USA).
Cell culture and transfection
Cell lines HeLa and 293T were cultured in DMEM containing 10% heat-inactivated fetal bovine serum (FBS), 1 Â nonessential amino acid, 100 mg/ml penicillin, 1 Â MEM sodium pyruvate, 100 mg/ml streptomycin (GIBCO, Grand Island, NY, USA) at 371C under an atmosphere of 5% CO 2 in air. Transfection of cells with various mammalian expression constructs by Lipofectamint 2000 (Invitrogen, Carsbad, CA, USA) was according to the methods provided by manufacturer's specification.
Plasmid construction
Primers that were used to generate plasmids encoding fulllength Mcl-1, full-length Puma and all their truncated deletion versions are listed in Table 1 . Plasmid (pHA-Puma) was a kind gift from Professor Bert Vogelstein (Johns Hopkins Medical Institution, Baltimore, MD, USA). The Mcl-1 cDNA was amplified by RT-PCR using total RNA from HeLa cell line as template. All Puma and Mcl-1 mutants were cloned into pEGFP-C1 (Clontech, Palo Alto, CA, USA) and pCDNA3-Flag (Invitrogen, USA) with EcoRI/BamHI and EcoRI/XbaI restriction sites, respectively.
PCR-mediated mutagenesis
PCR-mediated mutagenesis was carried out mainly as described previously (Sambrook and Russell, 2000) . All desired mutational changes by this method were finally verified by DNA sequencing.
Yeast two-hybrid screening
The full-length Puma was subcloned into plasmid pGBKT7 containing the GAL4 DNA-binding domain. The plasmid was transformed into Saccharomyces cerevisiae strain AH109. The evaluation and screening procedures were performed according to the manufacturer's instructions. Briefly, S. cerevisiae strain Y187 pretransformed with MATCH-MAKER library (Clonetech, Palo Alto, CA, USA) containing a human HeLa cDNAs fused to the GAL4 activation domain (AD) was mated with the AH109 strain harboring the Puma bait at 301C for 26 h with moderate shaking speed of Ade for 14 days at 301C. Positive colonies were screened for bgalactosidase activity using X-gal (5-bromo-4-chloro-3-indolylb-D-galactopyranoside) filter lift assay. Plasmids that activate all three yeast reporter genes (HIS2, ADE2 and LacZ) were isolated from positive diploid yeast colonies using lyticase method, propagated in E. coli and analysed by restriction mapping and automated sequencing.
Yeast two-hybrid assay
Yeast two-hybrid assay was performed as described previously (Fujise et al., 2000) . Briefly, S. cerevisiae AH109 cells were cotransformed with all the six possible combinations between (a) empty pGBKT7 and pGBKT7 containing a full-length Puma cDNA, and (b) empty pGADT7, pGADT7 containing full-length Mcl-1 and pGADT7 containing M01 (the original isolated Mcl-1 clone spanning the region from aa 132-350). Transformed cells were selected on SD plates lacking Trp and Leu (SD/-Trp/-Leu) for 7 days and subjected to X-gal filter lift assay. The blue color developed within 1 h was considered to represent a positive interaction.
Apoptosis assay
HeLa cells in 24-well plates were cultured to subconfluence (2 Â 10 4 cells/well) and transiently transfected with the indicated plasmids. 20 h post-transfection, the viability of cells was measured by counting GFP-positive apoptotic cells characteristic of aberrant nuclei staining by Hoechst 33342. The data represented the means7s.d. of at least three independent experiments.
Western blot analysis
Cultured cells were washed with 1 Â PBS and resuspended with 5 volumes of cold lysis buffer (50 mM Tris-HCl (pH 7.5), 250 mM NaCl, 5 mM EDTA, 50 mM NaF, 0.5% Nonidet P-40) supplemented with protease inhibitor cocktail (Roche Applied Science, Indianapolis, IN, USA). The samples were then boiled for 5 min, subjected to SDS-polyacrylamide gel electrophoresis, and transferred onto polyvinylidene difluoride membrane. The membrane was incubated with 5% nonfat milk in TBST (20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.1% Tween-20) for overnight at 41C, washed with TBST for 20 min, and then incubated with primary antibody for 1 h at room temperature. Blots were then probed with appropriate alkaline phosphataseconjugated secondary antibodies and proteins were visualized by using Promega Western Blue stabilized substrate for alkaline phosphatase.
Co-immunoprecipitation
Cells were lysed in a Nonidet P-40 based lysis buffer (0.5% NP-40, 150 mM NaCl, 20 mM HEPES, pH 7.5, 2 mM EDTA, 1.5 mM MgCl 2 ) supplemented with protease inhibitor cocktail for 30 min on ice, and the nuclear and cellular debris were cleared by centrifugation. The cytosolic lysate was incubated with indicated antibody bound to Protein A/G-Sepharose. After incubation at 41C for 4 h, the immunoprecipitates were washed five times in lysis buffer, and proteins were recovered by boiling the beads in SDS sample buffer and analysed using a Western blot.
Pulse-chase experiment
For the pulse-chase, cells were firstly washed with phosphatebuffered saline (PBS), starved in cysteine/methionine-free DMEM (DMEM-Cys þ -Met þ ) and chased with DMEM containing 10% FBS at 371C for the indicated amount of time. Cells were collected at each desired time point and lysed in RIPA buffer (50 mM Tris-HCl, pH 7.5, 1% Nonidet P-40, 0.1% SDS, 150 mM NaCl) supplemented with protease inhibitor cocktail. Immunoprecipitation was performed as described above with following modifications. The immunoprecipitates were washed five times with RIPA buffer and boiled in SDS sample buffer before they were subjected to SDS-PAGE followed by autoradiography. The amount of 35 S-labeled protein was quantified by PhosphorImager analysis.
Protein stability assay
HeLa cells in six-well plates were cultured to subconfluence and transiently transfected with indicated plasmids, followed by incubation at 371C for 24 h. The cells were treated with 25 mg/ml cycloheximide (CHX) for indicated periods of time and were then harvested and analysed by Western blotting as described above.
Mitochondria/cytosol fractionation
Cells were fractionated as previously described (Unkila et al., 2001) . HeLa cells transiently express indicated plasmids were gently scraped from six-well plates. Collected cells were washed twice with 1 Â PBS, resuspended in fresh cytosolic extract buffer (250 mM sucrose, 20 mM HEPES pH 7.4, 10 mM KCl, 1 mM EGTA, 1 mM EDTA, 1 mM MgCl 2 , 1mM dithiothreitol, and protease inhibitor cocktail) and incubated for 30 min on ice with frequent tube tapping. The nuclei, cell debris and unbroken cells were pelleted at 2500 r.p.m. for 10 min at 41C. The supernatant was further centrifuged at 13 000 r.p.m. for 20 min at 41C to pellet mitochondria. At last, the cytosolic extract was carefully transferred away from the mitochondrial pellet in order to avoid contamination and assessed by Western blotting.
Immunofluorescence microscopy
For detection of intracellular localization of overexpressed Mcl-1 and Puma, HeLa cells grown on glass coverslips were cotransfected with pEGFP/Mcl-1 and pCDNA3-Flag/Puma. At 24 h post-transfection, cells were washed once with PBS, fixed with 4% paraformaldehyde, permeabilized with 0.01% Triton X-100 in PBS, and blocked with 1% BSA in PBS for 30 min. Afterward, cells were incubated with primary anti-Flag monoclonal antibody for 1 h at room temperature and followed by incubation with Rhodamine-conjugated antimouse secondary antibodies for another 1 h. The cells were visualized under fluorescence microscope using standard filter for green or red fluorescence. Images were captured with a Zeiss Axioskop2 Plus fluorescence microscope (magnification Â 1000) controlled by image processing software named in situ imaging system (ISIS).
